Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Calmoseptine is a multi-purpose moisture barrier ointment originally developed by a pharmacist for use as a diaper rash treatment. It contains zinc oxide and menthol as its primary active ingredients. Zinc oxide acts as a skin protectant and mild astringent, providing a physical barrier against moisture and irritants such as urine and feces. Menthol serves as a topical analgesic and antipruritic, providing a cooling sensation and relieving pain and itching associated with skin irritation. The formulation is widely used in clinical settings for the prevention and treatment of incontinence-associated dermatitis (IAD), skin tears, and protection around feeding tube sites or wound drainage areas.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Calmoseptine.